Resources Blog The Role of Antibodies in Immunotherapy

The Role of Antibodies in Immunotherapy

Biointron 2024-01-20 Read time: 3 mins
Image credit: DOI: 10.1016/j.trecan.2022.01.008

Immunotherapy is a type of treatment that uses the body's own immune system to fight diseases, including cancer. One of the key players in immunotherapy is antibodies. 

Antibodies, also known as immunoglobulins, are proteins produced by B-cells that play a critical role in the immune system. They are responsible for identifying and neutralizing foreign substances, such as bacteria and viruses, by binding to them and marking them for destruction by other immune cells. 

In recent years, researchers have discovered that antibodies can also be used to target cancer cells. Antibody-based immunotherapies work by using monoclonal antibodies, which are antibodies that are made in the laboratory to target specific proteins on cancer cells. When the monoclonal antibodies bind to the cancer cells, they can trigger an immune response that leads to the destruction of the cancer cells. 

At Biointron, we are dedicated to accelerating antibody discovery for the development of new immunotherapies. Our expertise in antibody screening, engineering, and production allows us to provide high-quality antibody services that are critical to the success of immunotherapy research. 

Through our state-of-the-art manufacturing and automation process, we are able to deliver antibody products that meet international standards in terms of quality, purity, and potency. By working with us, our clients can rest assured that they are receiving the highest quality antibodies for their research and development needs. 

As the field of immunotherapy continues to grow and evolve, we are committed to staying at the forefront of antibody discovery and production. With our expertise and dedication to quality, we are proud to play a key role in the development of new immunotherapies that have the potential to transform the way we treat cancer and other diseases. 

Subscribe to our Blog

Recent Blog

Computational antibody methods schematic. DOI: 10.1093/bib/bbz095The development of therapeutic antibodies has been significantly enhanced by advancements in computational methods and artificial intelligence (AI). These technologies have streamlined the antibody discovery process, improving the abil

May 27, 2024

Welcometo Antibody Basics by Biointron,Part 8. In this episode, we’ll talk about therapeutics targeting cancer.What is cancer immunotherapy?Cancer immunotherapy leverages the body's immune system to fight cancer more selectively and effectively than traditional methods such as chemotherapy

May 24, 2024

The generation of an immune response to a vaccine. DOI: 10.1038/s41577-020-00479-7Vaccination is one of the most effective tools in preventing infectious diseases. At its core, the success of a vaccine hinges on its ability to induce a robust and lasting antibody response against a specific pathogen

May 22, 2024

Innovation orientation and goals for transforming CAR-T cell engineering. DOI: 10.1186/s13045-020-00910-5Chimeric antigen receptor (CAR)-T cell therapy is a revolutionary cancer treatment in which engineered CARs redirect lymphocytes, typically T cells, to recognize and destroy cells expressing a sp

May 20, 2024

Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.